Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Hospital Charity Care
  • Single-Payer Healthcare
  • TrumpRx
  • Pharmacy Discount Coupons
  • Decoding Health Insurance Terms

WHAT'S NEW

  • Hospital Charity Care
  • Single-Payer Healthcare
  • TrumpRx
  • Pharmacy Discount Coupons
  • Decoding Health Insurance Terms

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Apr 28 2021

Full Issue

Clamping Down On Drug Prices Stifles Innovation, Influential Analyst Says

Read about the biggest pharmaceutical developments and pricing stories from the past week in KHN's Prescription Drug Watch roundup.

FiercePharma: Do Pharma Buyouts Hurt Innovation And Lead To Higher Prices? Analyst Hits Back At FTC's Push For Tougher Reviews

In recent years, Democratic commissioners at the U.S. Federal Trade Commission (FTC) have clashed with their Republican counterparts over the agency's standards for large biopharma transactions. Now that they’ve come into power under the Biden administration, the Democrats have launched a sweeping review that threatens to clamp down on industry deal-making. One influential biopharma analyst disagrees with the FTC's stated reasoning for implementing tougher reviews. In fact, the new stance could be counterproductive, he argued. Large pharma consolidation can hurt R&D and lead to higher drug prices, Democratic commissioners have said. But those concerns are unfounded, SVB Leerink analyst Geoffrey Porges countered in a recent note to clients. (Liu, 4/26)

NJ.com: Cutting Prescription Drug Prices Should Be Next Biden Priority, Powerful N.J. Dem Says 

Angry over the high costs of prescription drugs. House Democrats campaigned on reducing drug costs when they won their majority in 2018. So did Joe Biden during his successful bid for president in 2020. On Thursday, Rep. Frank Pallone Jr. and other House committee chairs once again introduced legislation designed to lower drug costs after seeing a similar effort fall short when Republicans controlled the Senate. (Salant, 4/23)

MinnPost.com: House Bill Would Give New Board Power To Challenge Drug Prices In Minnesota 

Language in a 300-page Minnesota House commerce and energy omnibus spending bill would create a new state board that could challenge large increases in prescription drug prices. Under the bill, the seven-member board could conduct a cost review if it identified high introductory prices for new drugs or sizable price hikes for existing drugs. And if pricing were considered unjustified or unaffordable, the board could set caps on how much patients and health plans would have to pay.  (Callaghan, 4/26)

Today: 4 Ways To Save Money On Prescription Drugs And Lower The Cost

Does it ever seem like prescription drug prices are wildly varied? If you've made this observation, you're absolutely correct — in fact, the same drug can often have different prices depending on who is purchasing it and where. NBC News investigative and consumer correspondent Vicky Nguyen reported on a new online pharmacy that could help certain customers cut their costs on generic prescriptions. The company says that their average customer saves about $1000 a year. And in a time when we're all looking to save money, paying less for that medication can have a big impact. (Koenig, 4/21)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Monday, May 11
  • Friday, May 8
  • Thursday, May 7
  • Wednesday, May 6
  • Tuesday, May 5
  • Monday, May 4
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF